BerlinskiA. In vitro evaluation of positive expiratory pressure devices attached to nebulizers. Respir Care, 2014; 59(2):216–222.
2.
NataleJE, PfeifleJ, HomnickDN. Comparison of intrapulmonary percussive ventilation and chest physiotherapy: a pilot study in patients with cystic fibrosis. Chest, 1994; 105(6):1789–1793.
3.
HomnickDN, WhiteF, de CastroC. Comparison of effects of an intrapulmonary percussive ventilator to standard aerosol and chest physiotherapy in treatment of cystic fibrosis. Pediatr Pulmonol, 1995; 20(1):50–55.
4.
ReychlerG, KeyeuxA, CremersC, VeriterC, RodensteinDO, LiistroG. Comparison of lung deposition in two types of nebulization: intrapulmonary percussive ventilation vs jet nebulization. Chest, 2004; 125(2):502–508.
5.
ReychlerG, WallemacqP, RodensteinDO, CumpsJ, LealT, LiistroG. Comparison of lung deposition of amikacin by intrapulmonary percussive ventilation and jet nebulization by urinary monitoring. J Aerosol Med, 2006; 19(2):199–207.
6.
DellamonicaJ, LouisB, LyazidiA, VargasF, BrochardL. Intrapulmonary percussive ventilation superimposed on conventional ventilation: bench study of humidity and ventilator behavior. Intensive Care Med, 2008; 34(11):2035–2043.
7.
BerlinskiA, WillisJR. Albuterol delivery via intrapulmonary percussive ventilator and jet nebulizer in a pediatric ventilator model. Respir Care, 2010; 55(12):1699–1704.
8.
KarashimaT, Mimura-KimuraY, MiyakawaK, NakamuraA, ShimaharaF, KameiH, MimuraY. Variations in the efficiency of albuterol delivery and intrapulmonary effects with differential parameter settings on intrapulmonary percussive ventilation. Respir Care, 2019; 64(5):502–508.
9.
KlompasM, BransonR, EichenwaldE, GreeneLR, HowellM, LeeG, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol, 2014; 35(8):915–936.
10.
De CampoT, CivettaJM. The effect of short-term discontinuation of high-level PEEP in patients with acute respiratory failure. Crit Care Med, 1979; 7(2):47–49.
